Salvatore Brogna Sells 899 Shares of Intuitive Surgical, Inc. (ISRG) Stock
Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Salvatore Brogna sold 899 shares of Intuitive Surgical stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $1,001.90, for a total transaction of $900,708.10. Following the sale, the executive vice president now owns 570 shares of the company’s stock, valued at approximately $571,083. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
Intuitive Surgical, Inc. (NASDAQ ISRG) opened at 1006.75 on Friday. The company has a market cap of $37.40 billion, a price-to-earnings ratio of 48.22 and a beta of 0.38. The firm has a 50-day moving average of $961.09 and a 200-day moving average of $864.84. Intuitive Surgical, Inc. has a 52 week low of $610.71 and a 52 week high of $1,008.62. Intuitive Surgical’s stock is set to split before the market opens on Friday, October 6th. The 3-1 split was announced on Friday, August 11th. The newly issued shares will be payable to shareholders after the closing bell on Thursday, October 5th.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $1.98 EPS for the quarter, topping the consensus estimate of $1.93 by $0.05. The company had revenue of $756.20 million during the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The company’s quarterly revenue was up 12.8% on a year-over-year basis. During the same quarter last year, the firm posted $1.87 EPS. Equities analysts forecast that Intuitive Surgical, Inc. will post $23.92 earnings per share for the current year.
A number of research analysts recently issued reports on the stock. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $341.33 price objective for the company in a report on Wednesday, May 31st. Leerink Swann restated an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, July 5th. Morgan Stanley restated an “overweight” rating and set a $356.67 price objective (up previously from $316.67) on shares of Intuitive Surgical in a report on Tuesday, July 25th. Barclays PLC boosted their price objective on shares of Intuitive Surgical from $290.00 to $333.33 and gave the company an “overweight” rating in a report on Friday, July 21st. They noted that the move was a valuation call. Finally, Canaccord Genuity restated a “hold” rating and set a $333.33 price objective (up previously from $290.00) on shares of Intuitive Surgical in a report on Wednesday, July 26th. Five investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. Intuitive Surgical currently has an average rating of “Buy” and an average target price of $366.12.
Several hedge funds have recently made changes to their positions in the company. ETF Managers Group LLC bought a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $110,000. D. Scott Neal Inc. bought a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $120,000. Harvest Fund Management Co. Ltd bought a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $120,000. Guardian Life Insurance Co. of America increased its stake in shares of Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 3 shares during the period. Finally, Parallel Advisors LLC increased its stake in shares of Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock valued at $129,000 after buying an additional 14 shares during the period. 94.35% of the stock is owned by institutional investors.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.